Skip to main content

Lithium Induced Polyuria and Polydipsia

  • Chapter
Drugs, Systemic Diseases, and the Kidney

Abstract

It is well known that lithium carbonate, which is frequently used in the treatment of psychiatric disorders,can induce a syndrome characterized by polyuria and polydipsia (1). According to the various investigators, these clinical findings appear in a range between 20% and 70% of the patients treated (2,3,4,5,6,7). Lithium-induced polyuria and polydipsia may be due to primary polydipsia with secondary polyuria or to primary polyuria with secondary polydipsia. In support of the above-mentioned alternatives, it has been reported that lithium may stimulate thirst or may interfere with the ADH-dependent mechanisms. Experimental studies on rats have demonstrated that lithium can stimulate thirst (8,9,10,11). Other experimental studies on rats have demonstrated that lithium can deplete the posterior pituitary gland and the supra-optic nuclei of their neuro-endocrine material (12,13), showing that lithium may interfere with the synthesis, deposit and/or release of the ADH hormone, causing central diabetes insipidus. On the other hand, another cause which has been suggested is an interference by the lithium with the tubular renal action of the ADH, causing nephrogenic diabetes insipidus (14,15,16,17). In contrast, however, some authors were unable, under somewhat different experimental conditions, to detect a lithium-induced inhibition of the ADH -stimulated water flow in toads’ urinary bladders (18).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Schou, Lithium in psychiatric therapy, Psychopharmacologia.1: 65 (1959).

    Article  PubMed  CAS  Google Scholar 

  2. J.N. JR Forrest, A.D. Cohen, J. Torretti, J.M. Himmelhoch, F.H. Epstein, On the mechanism of lithium-induced diabetes insipidus in man and the rat, J. Clin. Invest. 53: 1115 (1974).

    Article  PubMed  CAS  Google Scholar 

  3. M. Schou, P.C. Baastrup, P. Grof, P. Weis, J.Angst, Pharmacological and clinical problems of lithium prophylaxis, Br. J. Psychiatry 116: 615 (1970).

    Article  PubMed  CAS  Google Scholar 

  4. J.L. Marini, M.H. Sheard, Sustained-release lithium carbonate in a double-blind study: serum lithium levels, side effects, and placebo response, J. Clin. Pharmacol. 16: 276 (1976)

    PubMed  CAS  Google Scholar 

  5. W.O. Williams, A.Z. Györy,Aspects of the use of lithium for the non-psychiatrist, Aust. NZ J. Med. 6: 233 (1976).

    Article  CAS  Google Scholar 

  6. P.L. Padfield, S.J. Park, J.J. Morton, A.E. Braidwood, Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy, Br. J. Psychiatry 130: 144 (1977).

    Article  PubMed  CAS  Google Scholar 

  7. P.H. Baylis, D.A. Heath, Water disturbances in patients treated with oral lithium carbonate, Ann. Incern. Med. 88: 607 (1978).

    CAS  Google Scholar 

  8. J.N. Galla, J.N. Forresit, B. Hecht, M. Kashgarian, J.P. Hayslett, Effect of liuhium on water and electrolyte metabolism, Yale J. Biol. Med. 48: 305 (1975).

    PubMed  CAS  Google Scholar 

  9. D.F. Smith, S. Balagura, M. Lubran, Antidotal thirst: a response to intoxication. Science 167: 297 (1970)

    Article  PubMed  CAS  Google Scholar 

  10. D.F. Smith, S. Balagura, Sodium appetite in rats given lithium. Life Sci. 11: 1021 (1972).

    Article  CAS  Google Scholar 

  11. M.H. Miskind, R.E. Greenspan, W.H. Bay, T.F. Ferris, Studies on lithium-induced polyuria, Clin.Res. 25: 596 A (1977).

    Google Scholar 

  12. G.L. Ellman, G.L. Gan, Lithium ion and water balance in rats, Toxicol. Appl. Pharmacol. 25: 617 (1973).

    Article  PubMed  CAS  Google Scholar 

  13. S. Hochman, Y. Gutman, Lithium: ADH antagonism and ADH independent action in rats with diabetes insipidus, Eur. J. Pharmacol. 28: 100 (1974).

    Article  PubMed  CAS  Google Scholar 

  14. I. Singer, D. Rotenberg, J.B. Puschett, Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies, J.Clin.Invest. 51: 1081 (1972).

    Article  PubMed  CAS  Google Scholar 

  15. I. Singer, E.A. Franko, Lichium-induced ADH resistance in road urinary bladders. Kidney Int. 3: 151 (1973).

    Article  PubMed  CAS  Google Scholar 

  16. C.A. Harris, F.A. Jenner, Some aspects of the inhibition of the action of antidiuretic hormone by lithium ions in the rat kidney and bladder of the toad Bufo marinus, Br. J. Pharmacol. 44: 223 (1972).

    Article  PubMed  CAS  Google Scholar 

  17. C. Torpr-Pederson, N.A. Thorn, Acute effects of lithium on the action and release of ADH in rats. Acta Endocrinol. (Kbh) 73: 665 (1973)

    Google Scholar 

  18. P.J. Bencley, A. Wasserman, The effects of lithium on the permeability of an epithelial membrane, the toad urinary bladder, Biochim. Biophys. Acta 266: 285 (1972).

    Article  Google Scholar 

  19. A. Tausch, H. Stegner, R.D. Leake, H.G. Artman, and D.A. Fisher, Radioimmunoassay of arginine vasopressin in urine: development and applicacion, J. Clin. Endo. & Merab. 57: 111 (1983)

    Google Scholar 

  20. P.D. Miller, S.L. Dubovsky, K.M. McDonald, F.H. Katz, G.L. Robertson, R.W. Schrier, Central, renal and adrenal effects of lithium in man. Am. J. Med. 66: 797 (1979).

    Article  PubMed  CAS  Google Scholar 

  21. P.L. Padfield, J.J. Morton, G.B.M. Lindop and G.C. Timbury, Lithium-induced nephrogenic diabetes insipidus; changes in plasma vasopressin and angiotensin II, Clin. Nephrol. 3: 220 (1975).

    CAS  Google Scholar 

  22. P.L. Padfield, S.J. Park, J.J. Morton and A.E. Braidwood, Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy, Brit. J. Psychiatry 130: 144 (1977).

    Article  CAS  Google Scholar 

  23. R.P. Hullin, V.P. Coley, N.J. Birch, T.H. Thomas, D.B. Morgan, Renal function after long-term treatment with lithium, Br.Med.J. 1: 1457 (1979).

    Article  PubMed  CAS  Google Scholar 

  24. A.J.M. Donker, E. Prins, S. Meijer, W.J. Sluiter, J.W.B.M. Van Berkestijn and L.C.W. Dols, A renal function study in 30 patients on long-term lithium therapy, Clin.Nephrol. 12: 254 (1979).

    PubMed  CAS  Google Scholar 

  25. M. Cox, I. Singer, Lithium and wauer metabolism. Am.J.Med. 59: 153 (1975).

    Article  PubMed  CAS  Google Scholar 

  26. D. Schlondorf, J.A. Satriano, Interactions of vasopressin, cAMP, and prostaglandins in toad urinary bladder. Am.J.Physiol. 248: F454 (1985).

    Google Scholar 

  27. K.H. Raymond, M.D. Lifschitz, Effect of prostaglandin on renal salt and water excretion. Am. J.Med. 80 (lA): 22 (1986).

    Article  PubMed  CAS  Google Scholar 

  28. T.P. Dousa, O. Hechter, The effect of NaCl and liCl on vasopressin-sensitive adenyl cyclase. Life Sci 9: 765 (1970).

    Article  CAS  Google Scholar 

  29. N.P. Beck, S.W. Reed, B.B. Davis, Effeccs of lithium on renal concentration of cyclic AMP, Clin. ‘Res. 19: 684 (1971).

    Google Scholar 

  30. A. Geisier, O. Wraae, O.V. Olesen, Adenyl cyclase activity in kidneys of rats with lithium-induced polyuria. Acta Pharmacol. Toxicol. (Kbh) 31: 203 (1972).

    Article  Google Scholar 

  31. T.B. Dousa, Lithium: interaccion with ADH dependent cyclic AI4P system of human renal medulla, Clin.Res. 21: 2 82 (1973).

    Google Scholar 

  32. G. Eknoyan, G.R. Corey, J. Loomis, W.N. Suki, M. Martinez-Maldonado, Lithium-induced diabetes insipidus: effect on urinary cyclic AMP excretion and renal tissue adenylate cyclase activity, Clin.Res. 22: 524 (1974).

    Google Scholar 

  33. G.W. Rutecki, J.V. Nally, W.H. Bay, T.F. Ferris, The acute effects of lithium (Li) on renal function (abstract), Xth Annual Meeting American Society of Nephrology, Washington, D.C., November 20–22 (1977).

    Google Scholar 

  34. J. Orloff, J.S. Handler, S. Bergstrom, Effect of prostaglandin PGE, on the permeability response of toad bladder to vasopressin, theophylline, and adenosine 3’ – 5’– monophosphate. Nature 205: 397 (1965).

    Article  PubMed  CAS  Google Scholar 

  35. J.J. Grantham, J.Orloff, Effect of prostaglandin E on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3’ – 5’– monophosphate, and theophylline, J.Clin. Invest. 47: 1154 (1968).

    Article  PubMed  CAS  Google Scholar 

  36. F. Marumo, J.S. Eelman, Effects of Ca++ and prostaglandin E on vasopressin activation of renal adenyl cyclase, J.Clin.Invest. 50: 1613 (1971).

    Article  PubMed  CAS  Google Scholar 

  37. A. Kalisker, D.C. Dyler, Inhibition of the vasopressinactivated adenyl cyclase from renal medulla by prostaglanins, Eur. J. Pharmacol. 20: 143 (1972).

    Article  PubMed  CAS  Google Scholar 

  38. G.M. Lum, G.A. Aisenbrey, M.J. Dunn, T. Berl, R.W. Schrier, K.M. McDonald, In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin, J.Clin.Invest. 59:8 (1977).

    Article  PubMed  CAS  Google Scholar 

  39. R. Locher, W. Vetter, L.H. Block, Interactions between 8-L-arginine vasopressin and prostaglandin E in human mononuclear phagocytes, J.Clin.Invest 71: 884 (1983).

    Article  PubMed  CAS  Google Scholar 

  40. R.B. Clark, R.W. Butcher, Desensitization of adenylate cyclase in cultured fibroblasts with prostaglandin E and epinephrine, J.Biol.Chem. 254: 9373 (1979).

    PubMed  CAS  Google Scholar 

  41. S. Kassis, P.H. Fishman, Different mechanism of desensitization of adenylate cyclase by isoproterenol and prostaglandin E in human fibroblasts, J.Biol.Chem. 2 57: 5312 (1982).

    Google Scholar 

  42. R.M. Burch, P.V. Malushka, 45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport, J.Pharmacol. Exp. Ther. 224: 108 (1983).

    PubMed  CAS  Google Scholar 

  43. S.P. Nadler, S.C. Hebert, B.M. Brenner, Cholera toxin, forskolin, and PGE interactions in isolated perfused rabbit cortical collecting tubules (abstr.) Am.Soc.Nephrol. 17: 233 (A) (1984).

    Google Scholar 

  44. D. Schlondorff, C.P. Carvounis, Jacoby M., J.A. Satriano, and S.D. Levine, Multiple sites for interactions of prostaglandin and vasopressin in toad urinary bladder. Am. J. Physiol. 241: F625 (1981)

    PubMed  CAS  Google Scholar 

  45. L. Somova, S. Zaharieva, M.Ivanova, Humoral factors involved in the regulation of sodium-fluid balance in normal man. Acta Physiol. Pharmacol. Bulg. 10: 29 (1984).

    PubMed  CAS  Google Scholar 

  46. J.R. Anderson, T. Berl, K.M. McDonald, and R.W. Schrier, Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney, J.Clin. Invest. 56: 420 (1975).

    Article  PubMed  CAS  Google Scholar 

  47. T. Berl, A. Raz, H. Wald, J. Horowitz, and W. Czaczkes, Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am.J.Physiol. 232: F529 (1977).

    PubMed  CAS  Google Scholar 

  48. H.J. Kramer, A. Backer, S. Hinzen, R. Dusing, Effects of inhibition of prostaglandin-synthesis on renal electrolyte excretion and concentrating ability in healthy man. Prostaglandins Med. 1:341 (1978)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Passavanti, G., Buongiorno, E., De Fino, G., Rutigliano, G., Giannattasio, M., Coratelli, P. (1989). Lithium Induced Polyuria and Polydipsia. In: Amerio, A., Coratelli, P., Campese, V.M., Massry, S.G. (eds) Drugs, Systemic Diseases, and the Kidney. Advances in Experimental Medicine and Biology, vol 252. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8953-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8953-8_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8955-2

  • Online ISBN: 978-1-4684-8953-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics